NCT02958852 2025-09-10
ABC-SE
Lund University Hospital
Phase 2 Completed
Clinical Trials
8 trialsNCT06067503 2025-04-22
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
NCT02035813 2024-06-04
DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
University of Ulm
Phase 2 Completed
NCT04993014 2021-08-06
HER2Cell
AC Camargo Cancer Center
Phase 2 Recruiting
NCT01548677 2019-03-13
TREAT-CTC
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT03070002 2018-11-20
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells
Northwestern University
Phase 2 Terminated
NCT02602938 2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2 Unknown
NCT00429182 2013-04-10
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed